It is desirable in many studies to be able to rapidly measure rates of erythrocyte and hemoglobin destruction. Labeling techniques have been utilized for this purpose but have the disadvantage of requiring several days' to weeks to obtain the desired data plus the hazards of radioactive isotopes. Estimations of hemoglobin turnover from measurements of fecal bile pigment or serum bilirubin concentrations contain large sources of error (1). Studies in which bile pigment is collected via bile duct fistulas have been of value in animal experiments (2) but are -not usually possible in man, and subjects who have bile fistulas cannot be called normal. At the present time it appears that many in vivo investigations of red cell survival in patients with hemolytic disease are limited by the lack of a precise rapid method for detecting changes in the rate of red cell destruction.
It is desirable in many studies to be able to rapidly measure rates of erythrocyte and hemoglobin destruction. Labeling techniques have been utilized for this purpose but have the disadvantage of requiring several days' to weeks to obtain the desired data plus the hazards of radioactive isotopes. Estimations of hemoglobin turnover from measurements of fecal bile pigment or serum bilirubin concentrations contain large sources of error (1) . Studies in which bile pigment is collected via bile duct fistulas have been of value in animal experiments (2) but are -not usually possible in man, and subjects who have bile fistulas cannot be called normal. At the present time it appears that many in vivo investigations of red cell survival in patients with hemolytic disease are limited by the lack of a precise rapid method for detecting changes in the rate of red cell destruction.
It has been shown previously (3) (4) (5) (6) (7) (8) (9) that CO is an in vivo catabolic by-product of hemoglobin and that it probably originates from the heme a-methine bridge carbon atom. Data obtained in experiments where CO production was measured after intravenous injections of suspensions of damaged erythrocytes or solutions of hemoglobin have indicated that the molar yield of CO produced to heme catabolized is approximately unity in normal man (6) and anesthetized dogs (9) . Apparently, therefore, the measurement of CO production is useful in studying hemoglobin and red cell turnover and can be utilized in studies of patients with increased erythrocyte destruction. The quantitation of erythrocyte and hemoglobin 'catabolism from CO production measurements has the advantages that it is rapidly accomplished, does not require isotopes, and can be repeated.
Early workers (4, 10) attempted to estimate red cell survival with measurements of the venous blood carboxyhemoglobin per cent saturation ([COHb] ) in patients with hemolytic anemia; this approach seems inadequate in view of the uncertainties of the relationship of [COHbJ to the actual rate of CO production in these patients ( 11) . The development of a method of estimating the rate of CO production (Nrco) based on 'the measurement of the rate of increase in CO body stores under conditions where CO excretion from the body is prevented by having the subject rebreathe in a closed system has apparently circumvented this difficulty (5) .
In the present report we describe a modification of the rebreathing system that has allowed us to measure Vco in seriously ill and debilitated patients. With this system Vco has been determined in seven patients with hemolytic anemia. The results show that the measurement can be used to quantitate erythrocyte and hemoglobin destruction in' these patients and that there is a fraction of the Vco that apparently cannot be explained on the basis of catabolism of circulating hemoglobin.
60
Material may be protected by copyright law (Title 17, U.S. Code) SUBJECT. Endogenous CO production was "simulated" by adding CO to the rebreathing system every 30 minutes for 2 hours. The "rate of CO production" was determined in the usual manner by measuring the rate of increase in blood carboxyhemoglobin per cent saturation and calculating the rate of increase in the body CO stores. In this experiment 3.64 ml CO per hour was added. The measured rate of CO increase in the body was 4.00 il per hour. The difference is entirely explainable by endogenous CO production.
lung volume is approximately 12 L. In designing this system we kept the volume as small as possible to minimize CO loss from the body into gas, which occurs as [COlHb] increases during the procedure. The CO loss that could occur in our system from this process is less than 0.02 pmiole per hour in a normal subject.
J)uring most of the studies we checked the system for leaks by injecting small quantities of neon into the gas in the rebreathing system and monitoring the neon concentration in this gas with a gas chromatograph. In all of the studies the neon concentration decreased slightly during the first 30 minutes and then remained constant during the remainder of the study. The initial decrease in neon concentration presumably resulted from wash-in of neon into the lungs and solubility in body tissues rather than leakage out of the system. Although the system proved to be free of leaks, the Vco measurement is not highly sensitive to leaks. A leak of I L out of the system in 2 hours would cause an error of less than 0.5
Mmole per hour in measured Vco in a normal subject; leaks into the system would result in proportionately smaller error, since the CO concentration in room air is usually less than in the equilibrated air in the rebreathing system. Simulated CO production experimehts. We performed two experiments designed to measure the precision of the rebreathing method and determine if the precision of ±3.1 gmoles per hour (SD) (0.07 ml per hour) could be achieved when \Tco was elevated. A. known amount of CO was periodically added to the body stores by injecting CO into the rebreathing gas. The rate of CO inj ection was compared with the measured XTco calculated from the rate of increase in [COHb] . Data from an experiment performed on a normal male subject are shown in Figure 2 . The patient initiated breathing in the closed system. A venous blood sample was drawn, and 1.82 ml (standard temperature and pressure, dry) of CO was added to the rebreathing system. This sequence was repeated every 30 minutes so that 3.64 ml of CO was added per hour to the body stores. Measured Vco was 4.00 ml per hour. The difference between the simulated Vco and measured Vco was 0.36 ml per hour and is entirely explainable on the basis of normal endogenous CO production. The Vco in normal young male subjects averages 0.42 (SD ± 0.07) ml per hour (5 t In these patients we measured serum folic acid (17) and urine formiminoglutamic and urocanic acids after a histidine load (18 Vco was again 3.64 ml per hour, and measured 'Vco was 3.70 ml per hour. The average endogenous Vco found in anesthetized dogs is 0.18 (SD + 0.08) ml per hour (9) . These experimental results suggest that the precision of the measurement is similar with normal and markedly elevated Vco. Measurement of erythrocyte and hemoglobin destruction rates. Erythrocyte survival studies were performed with radiochromate by the method of Read (14) except that acid-citrate-dextrose anticoagulant was used. The method was then nearly identical to that of Cline and Berlin (15) . These data were expressed as a half-time, ti, the time at which blood radioactivity reached 50%o of the initial value. From this we calculated the time constant, K, using the following equation which assumes that erythrocyte destruction was random: N = No e"t. No is the initial red cell radioactivity at zero time, N the radioactivity at time t, and K the time constant in per cent per day. K was corrected for elution, assuming this process is constant and exponential and equal to 1.29%o per day (15) giving a corrected time constant K'. The rate of blood heme destruction was calculated by multiplying K' and the total body hemoglobin calculated from the CO dilution measurements (16) . The results are expressed as micromoles heme destroyed per hour.
The patients used in this study had documented hemolytic diseases. Vital statistics and diagnoses are listed in Table I . All of the patients were thought to be clinically in a stable or steady state. Five of the seven patients were brought into the hospital specifically for this study. Drug regimens were not changed during the study period. None of the patients had been transfused for 3 months before the study. One of the patients (FS) was studied completely at two different stages of his disease (May and November of 1962). Three of the patients (BS, FS, and CJ), were smokers but were not allowed to smoke for 2 days before the Vco measurements; the remainder of the patients denied smoking.
Results
Total body hemoglobin, 51Cr t4, and calculated K' values are listed for each patient in Table I Table II shows the data on CO production in these patients. The venous blood [COHb] of the first sample drawn in each study was greater than normal in seven of the eight studies, ranging from 0.77 to 2.62%o. The average [COHb] in patients without hemolytic disease is 0.88 + 0.11% (SD) (12) . ' actual measured data and demonstrates the precision with which the rate of increase in blood carboxyhemoglobin can be determined. These duplicate studies were performed at 1-to 2-day intervals. The regression lines were drawn by "least squares." The rate of CO production is calculated from these data and CO dilution in the body (5 Figure 3 shows the increase in blood [COHb] in four patients studied on two occasions and illustrates the reproducibility and precision of the method.
Vco is compared to Vheme in Figure 4 , where both are plotted in micromoles per hour. The data obtained from the patients with hemolytic anemia are plotted in closed circles, and the average Vco and calculated Vheme in ten normal supine male subjects at rest (5) Figure 5 . The correlation coefficient between these variables is + 0.59.
Discussion
The rebreathing system developed for this study has made the measurement of Vco clinically feasible. Only two of the first twenty patients studied were not able to complete the procedure: one was a 70-year-old man with arteriosclerotic heart disease who could not lie flat as required with the present equipment.
In this study elevated Vco and blood [COHb] were found in seven patients with hemolytic anemia. The finding of elevated [COHb] in these patients confirms the report of Engstedt (10) In the present study those patients with the shortest red cell survival times had the highest Vco values, suggesting the Vco might be used to quantitate red cell destruction rates. Since the error in the Vco measurement is very small (less than 5%o of total Vco in these patients), the precision with which erythrocyte destruction could be quantitated would depend on a) whether CO was produced as a result of processes other than catabolism of hemoglobin in significant amounts and b) whether the molar yield of heme to CO (5) . Rate of CO production was measured directly; rate of circulating heme catabolism was calculated from 51Cr-labeled erythrocyte decay curves. The solid line is a least squares regression line and was drawn through the "hemolytic" data. This regression line has a slope of 1.04. The interrupted line is drawn for a molar ratio of Vco/Vheme equal to unity.
varied when the rate of hemoglobin catabolism was markedly increased.
Evidence is available that CO arises from processes other than circulating hemoglobin catabolism.
In normal man approximately 20% of the Vco cannot be explained on the basis of destruction of hemoglobin from circulating erythrocytes (5) .
It is of interest that this "extra" CO is of the same magnitude as the "extra" stercobilin, which does not arise from circulating hemoglobin (19) . It has recently been shown (20) that 14CO appears in the expired air of humans shortly after the administration of glycine-2-14C and that the CO specific activity parallels that in bile pigment. These findings suggest a common molecular origin or origins for extra CO and extra bile pigment. Extra bile pigment, sometimes called "shunt" bile pigment, is thought to originate as a result of ineffective erythropoiesis (catabolism of immature erythrocytes in the bone marrow, or short-lived cells in the circulation) or as a by-product of porphyrin metabolism in the liver, or both (19, (21) (22) (23) . It would be expected in patients with hemolytic anemia that the quantity of CO originating from catabolism of erythrocytes might be very large compared to that originating from these other sources, since the turnover of erythrocytes is so rapid.
To determine the per cent of total CO production arising from destruction of circulating erythrocytes in our patients, we estimated the rate of erythrocyte hemoglobin catabolism from 51Cr-labeled red blood cell measurements and compared this value, expressed as Vheme, with Vco. The estimation of Vheme from 51Cr curves has many inherent errors. It requires an assumption regarding the mechanism of hemolysis and has uncertainties regarding a) elution of chromate from the labeled erythrocytes and b) steady state. The calculation of Vheme is in addition affected by errors in measuring total red blood cell mass; however, this error cancels out in the comparison of Vheme and Vco, since the red blood cell mass measurement is used in the calculation of Vco as well.
In all the patients the curve of disappearance of 51Cr from the blood was exponential, and it therefore appeared that the hemolytic mechanism was random. Six of the seven patients had either S-S disease or autoimmune hemolytic anemia, and in these conditions others have reported that red cell destruction is random (24, 25) . We, therefore, assumed that destruction was random in all the patients. The error from some degree of nonrandom destruction in these patients would be small; for example, if one-half of the red cells were destroyed in a nonrandom fashion, assuming a random mechanism would lead to an overestimation of Vheme of only 12%o.
The recent study of Cline and Berlin (15) has made it possible to estimate errors in 51Cr red blood cell survival measurements arising from uncertainty regarding the rate of elution of the label from the injected cells. These investigators measured decay curves of erythrocytes labeled simultaneously with 32diisopropyl fluorophosphate, 14C, and 51Cr in 38 patients who had a variety of hematological diseases. It was assumed that the difference in decay rates between 51Cr and the other labels was due to chromium elution. The rate of elution was found to be constant in most of the patients, was not related to the rate of hemolysis or the disease, and averaged 1.29%o per day. We have calculated the standard deviation from the data presented by Cline and Berlin in this paper and found it to be ± 0.42%o per day. This uncertainty in chromate elution rate is relatively small compared to our average rate decrease in 51Cr radioactivity of 7.6% per day; the average error in Vheme resulting from variation in elution rates should be considerably less than 10%. Even if any of our patients were at the extremes of the rates of chromium elution reported by Cline Gray and Scott (21) , who stimulated erythropoiesis in one man by hemorrhage and found an increase in shunt bile pigment. Furthermore, in patients with sickle cell anemia (26) the plasma radioiron turnover ratio is increased followed by reduced red cell radioiron incorporation, as is seen in patients with the ineffective erythropoiesis syndrome. It seems unlikely that the extra CO found in our patients could be explained on the basis of folic acid deficiency. The serum folic acid levels and quantities of histidine metabolites in the urine were found to be normal in three of four patients where these measurements were performed as indicated in Table I .
Estimation of mean erythrocyte life-span from CO production. The mean erythrocyte life-span (MLS) can be considered to be equal to the total body hemoglobin (Theme) divided by the quantity of hemoglobin destroyed per day if a steady state exists where the rate of hemoglobin destruction equals the rate of production. Since CO is probably produced in a molar ratio to blood heme catabolized in these patients, the following relationship should exist: MLS = Theme (micromoles) / Vco (micromoles per day). In Because of the extra CO fraction, MLS should be calculated from Vco as above, and then the "actual" life-span can be read from the abscissa in Figure 6 . MLS can be computed from the Vco in this manner in our series with an error of only ± 3 days compared to the chromium method.
If most of the extra CO originates as a result of ineffective erythropoiesis, calculation of erythrocyte life-span from 'Vco without correction might indicate the average life-span of all erythrocytes, not just those labeled in the circulation. The mean erythrocyte life-span calculated from Vco without correction for extra CO may also prove to be a most useful determination when compared with results of measurements obtained by labeling circulating erythrocytes with radioactive tracers.
Summary
We have investigated the relationship of endogenous carbon monoxide production to red blood cell and hemoglobin catabolism in seven patients with hemolytic anemia. The rate of carbon monoxide production was markedly elevated in all of the patients. The rate of carbon monoxide production was found to correlate closely with the rate of blood heme destruction calculated from radiochromate red blood cell labeling studies (r = + 0.94). Greater amounts of carbon monoxide were produced in six of eight studies than could be explained on the basis of blood heme catabolism. The average molar ratio was 1.41 + 0.28 (SD). We suggest that the fraction of CO apparently not explainable on the basis of circulating hemoglobin catabolism, "extra CO," is a by-product of the metabolic processes that cause "shunt" bile pigment. Mean erythrocyte life-spans can be calculated from the rate of carbon monoxide production corrected for extra CO with an error of ± 3 days (SD).
